These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 4016772)

  • 1. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
    Marsh JC; Shoemaker RH; Suffness M
    Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.
    Marsh JC; Shoemaker RH; Salmon SE; Kern DH; Venditti JM
    Int J Cell Cloning; 1988 Jan; 6(1):60-8. PubMed ID: 3339266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of P388 leukemia with benzaldehyde.
    Balázová E; Koza I
    Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
    Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of antitumor screening relative to activity criteria.
    Paull K; Hodes L; Simon RM
    J Natl Cancer Inst; 1986 Jun; 76(6):1137-42. PubMed ID: 3458950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2,3,4,-Tetrahydro-1,2-diazepine derivatives: synthesis and evaluation of antileukemic activity.
    Dal Piaz V; Ciciani G
    Farmaco Sci; 1988 Nov; 43(11):943-9. PubMed ID: 3251787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
    Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
    Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.
    Montgomery JA
    Cancer Treat Rep; 1980; 64(8-9):987-91. PubMed ID: 7448833
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
    Russo P; Favoni RE; Zarcone D; Miglietta L; Peluso M; Nicolin A; Bignone F; Parodi S
    Anticancer Res; 1986; 6(6):1297-304. PubMed ID: 3813486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age on antileukemic action, subacute toxicity and tissue distribution of ambazone in B6D2F1 mice.
    Amlacher R; Baumgart J; Härtl A; Weber H; Kühnel HJ; Schulze W; Hoffmann H
    Arch Geschwulstforsch; 1990; 60(1):11-8. PubMed ID: 2310296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
    Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
    Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
    Dumont P; Fuks R; Atassi G; Hanocq M
    J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance studies on intraspecific hybridomas.
    Pályi I; Turi G; Szikla K; Dallmann L
    Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characterization of three new spontaneous mouse lymphomas and comparison with the leukemia P388.
    Baumgart J; Güttner J; Zborowska E; Czarnomska A
    Arch Geschwulstforsch; 1988; 58(4):223-33. PubMed ID: 3421809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Gan; 1979 Oct; 70(5):607-13. PubMed ID: 520752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.